MARSHALL WACE, LLP - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 125 filers reported holding CYTOKINETICS INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$45,190,727
+442.4%
1,533,969
+500.6%
0.09%
+475.0%
Q2 2023$8,330,887
-68.2%
255,392
-65.7%
0.02%
-71.4%
Q1 2023$26,227,353
-43.4%
745,307
-26.3%
0.06%
-46.2%
Q4 2022$46,345,189
+0.1%
1,011,462
+5.8%
0.10%
+3.0%
Q3 2022$46,313,000
-12.9%
955,886
-29.4%
0.10%
-7.3%
Q2 2022$53,164,000
+4571.7%
1,353,137
+4278.4%
0.11%
+5350.0%
Q1 2022$1,138,000
-43.5%
30,905
-30.0%
0.00%
-50.0%
Q4 2021$2,014,000
-23.2%
44,171
-66.7%
0.00%
-66.7%
Q2 2021$2,622,000
-58.8%
132,497
-51.6%
0.01%
-58.6%
Q1 2021$6,371,000
+486.6%
273,906
+423.9%
0.03%
+383.3%
Q4 2020$1,086,000
-75.8%
52,278
-74.8%
0.01%
-79.3%
Q3 2020$4,491,000
+3354.6%
207,453
+1197.2%
0.03%
+2800.0%
Q1 2019$130,000
+154.9%
15,992
+100.0%
0.00%0.0%
Q4 2018$51,000
-76.8%
7,996
-73.9%
0.00%
-88.9%
Q1 2018$220,00030,6000.01%
Other shareholders
CYTOKINETICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders